Order Article Reprints

Bernardini N, Marotta G, Skroza N, Graceffa D, Bragazzi MC, Finistauri Guacci L, Tolino E, Sasso FP, Gallo U, Richetta AG, et al. Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage. Clinics and Practice. 2026; 16(8):146. https://doi.org/10.3390/clinpract16080146

Bernardini, Nicoletta, Giorgio Marotta, Nevena Skroza, Dario Graceffa, Maria Consiglia Bragazzi, Lucia Finistauri Guacci, Ersilia Tolino, Francesca Paola Sasso, Umberto Gallo, Antonio Giovanni Richetta, and et al. 2026. "Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage" Clinics and Practice 16, no. 8: 146. https://doi.org/10.3390/clinpract16080146

Bernardini, N., Marotta, G., Skroza, N., Graceffa, D., Bragazzi, M. C., Finistauri Guacci, L., Tolino, E., Sasso, F. P., Gallo, U., Richetta, A. G., & Dattola, A. (2026). Guselkumab Every 4 Weeks as a Real-World Therapeutic Option for Psoriatic Arthritis Patients at High Risk of Joint Damage. Clinics and Practice, 16(8), 146. https://doi.org/10.3390/clinpract16080146